臨牀消化器内科 Vol.33 No.4(5-5)


特集名 慢性便秘―新たな分類と病態・診断・治療
題名 治療(5)プロバイオティクス
発刊年月 2018年 04月
著者 岡田 義清 防衛医科大学校内科学第2
著者 穂苅 量太 防衛医科大学校内科学第2
【 要旨 】 「宿主に健康効果を示す生きた微生物またはそれを含む食品」と定義されるプロバイオティクスは,いわゆる善玉菌を増やし悪玉菌を退治することを利用した整腸作用を有しており,以前より慢性便秘に対して整腸剤として用いられてきた.近年,プロバイオティクスが一般社会へ認知されつつあり,慢性便秘への有効性を実証するためのランダム化比較試験やメタアナリシスを含めた報告が増加している.多くの報告では,プロバイオティクス投与は,腹部症状を悪化させることなく排便回数の有意な増加が認められ,一部の報告では,便の性状改善,残便感,排便時痛などの自覚症状の改善についても有効性が示されている.今後,さらなるエビデンスの蓄積と慢性便秘におけるdysbiosisとの関連性などの解明が待たれている.
Theme Chronic Constipation : A New Classification, Pathophysiology, Diagnosis, Treatment
Title Effects of Probiotic Administration on Chronic Constipation and Current Status of Clinical Application
Author Yoshikiyo Okada Department of Internal Medicine, National Defense Medical College
Author Ryota Hokari Department of Internal Medicine, National Defense Medical College
[ Summary ] Probiotics are currently defined as "living microorganisms or foods containing them, which when consumed in adequate amounts, confer a health effect on the host". Probiotics strains have intestinal disorder‒controlling action for their fundamental action which is derived from increasing the number of beneficial intestinal microorganism and decreasing the number of harmful intestinal microorganisms, and studies into their clinical applications to chronic constipation have been attempted. Recent studies on probiotics for the treatment of patients with chronic constipation under randomized control trial or meta‒analysis have demonstrated that probiotics did lead to a significant improvement in the mean number of stools without ingravescence of abdominal symptoms. In addition, several studies have reported improvement of subjective symptoms such as hardness of the stool, a feeling of incomplete evacuation or stomachache during defecation. In the future, accumulation of further evidence and elucidation of the relationship between imbalance of the composition of the intestinal microbiota (dysbiosis) and patients with chronic constipation are needed.
戻る